107
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel versus carboplatin/docetaxel in initial treatment of metastatic Her-2-negative breast cancer

, , , &
Pages 37-42 | Published online: 17 Jun 2013